These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32905596)

  • 1. Retinoic acid-responsive CD8 effector T cells are selectively increased in IL-23-rich tissue in gastrointestinal GVHD.
    Ball JA; Clear A; Aries J; Charrot S; Besley C; Mee M; Stagg A; Lindsay JO; Cavenagh J; Calaminci M; Gribben JG; Davies J
    Blood; 2021 Feb; 137(5):702-717. PubMed ID: 32905596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low percentages of circulating CD8(+)/CD45RA(+) human T lymphocytes expressing beta7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Avanzini MA; Maccario R; Locatelli F; Giebel S; Santos CD; Bernardo ME; Pagliara D; Montagna D; Longo S; Amendola G; Marconi M
    Exp Hematol; 2006 Oct; 34(10):1429-34. PubMed ID: 16982336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin attenuates acute gastrointestinal graft-versus-host disease by preventing apoptosis of intestinal epithelial cells.
    Kawakami K; Minami N; Matsuura M; Iida T; Toyonaga T; Nagaishi K; Arimura Y; Fujimiya M; Uede T; Nakase H
    Biochem Biophys Res Commun; 2017 Apr; 485(2):468-475. PubMed ID: 28192120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical role for the retinoic acid signaling pathway in the pathophysiology of gastrointestinal graft-versus-host disease.
    Chen X; Dodge J; Komorowski R; Drobyski WR
    Blood; 2013 May; 121(19):3970-80. PubMed ID: 23529927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel role for surfactant protein A in gastrointestinal graft-versus-host disease.
    Gowdy KM; Cardona DM; Nugent JL; Giamberardino C; Thomas JM; Mukherjee S; Martinu T; Foster WM; Plevy SE; Pastva AM; Wright JR; Palmer SM
    J Immunol; 2012 May; 188(10):4897-905. PubMed ID: 22508928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation and host retinoic acid signaling promote the induction of gut-homing donor T cells after allogeneic hematopoietic stem cell transplantation.
    Zheng J; Taylor B; Dodge J; Stephans A; Zheng SG; Chen Q; Chen X
    Am J Transplant; 2020 Jan; 20(1):64-74. PubMed ID: 31207088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of allogeneic CD8+ T-cell response by DZNep controls GVHD while preserving hematopoietic chimerism.
    Wang J; Li L; Xu M; Rong R; Zhu T
    Transplantation; 2013 Nov; 96(9):774-81. PubMed ID: 23900211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic Cell Expression of Retinal Aldehyde Dehydrogenase-2 Controls Graft-versus-Host Disease Lethality.
    Thangavelu G; Lee YC; Loschi M; Schaechter KM; Feser CJ; Koehn BH; Nowak EC; Zeiser R; Serody JS; Murphy WJ; Munn DH; Chambon P; Noelle RJ; Blazar BR
    J Immunol; 2019 May; 202(9):2795-2805. PubMed ID: 30885956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
    Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
    Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell-specific notch inhibition blocks graft-versus-host disease by inducing a hyporesponsive program in alloreactive CD4+ and CD8+ T cells.
    Sandy AR; Chung J; Toubai T; Shan GT; Tran IT; Friedman A; Blackwell TS; Reddy P; King PD; Maillard I
    J Immunol; 2013 Jun; 190(11):5818-28. PubMed ID: 23636056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD.
    Alho AC; Kim HT; Chammas MJ; Reynolds CG; Matos TR; Forcade E; Whangbo J; Nikiforow S; Cutler CS; Koreth J; Ho VT; Armand P; Antin JH; Alyea EP; Lacerda JF; Soiffer RJ; Ritz J
    Blood; 2016 Feb; 127(5):646-57. PubMed ID: 26670634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of graft-versus-host disease: a biomarker panel based on lymphocytes and cytokines.
    Budde H; Papert S; Maas JH; Reichardt HM; Wulf G; Hasenkamp J; Riggert J; Legler TJ
    Ann Hematol; 2017 Jul; 96(7):1127-1133. PubMed ID: 28447161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. γδ T Cells May Aggravate Acute Graft-Versus-Host Disease Through CXCR4 Signaling After Allogeneic Hematopoietic Transplantation.
    Wu N; Liu R; Liang S; Gao H; Xu LP; Zhang XH; Liu J; Huang XJ
    Front Immunol; 2021; 12():687961. PubMed ID: 34335589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic regulation of effector IFN-γ-producing and IL-17-producing T cell subsets in the development of acute graft-versus-host disease.
    Zhao K; Ruan S; Yin L; Zhao D; Chen C; Pan B; Zeng L; Li Z; Xu K
    Mol Med Rep; 2016 Feb; 13(2):1395-403. PubMed ID: 26647759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
    Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB
    Front Immunol; 2018; 9():3104. PubMed ID: 30733722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IL-33/ST2 axis augments effector T-cell responses during acute GVHD.
    Reichenbach DK; Schwarze V; Matta BM; Tkachev V; Lieberknecht E; Liu Q; Koehn BH; Pfeifer D; Taylor PA; Prinz G; Dierbach H; Stickel N; Beck Y; Warncke M; Junt T; Schmitt-Graeff A; Nakae S; Follo M; Wertheimer T; Schwab L; Devlin J; Watkins SC; Duyster J; Ferrara JL; Turnquist HR; Zeiser R; Blazar BR
    Blood; 2015 May; 125(20):3183-92. PubMed ID: 25814531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Inflammatory T Helper Cells
    Buchele V; Abendroth B; Büttner-Herold M; Vogler T; Rothamer J; Ghimire S; Ullrich E; Holler E; Neurath MF; Hildner K
    Front Immunol; 2018; 9():1138. PubMed ID: 29910804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational Clinical Strategies for the Prevention of Gastrointestinal Tract Graft
    Rayasam A; Drobyski WR
    Front Immunol; 2021; 12():779076. PubMed ID: 34899738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Donor Vitamin A Deficiency and Pharmacologic Modulation of Donor T Cell Retinoic Acid Pathway on the Severity of Experimental Graft-versus-Host Disease.
    Dodge J; Stephans A; Lai J; Drobyski WR; Chen X
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2141-2148. PubMed ID: 27596131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of highly effective and stable murine alloreactive Treg cells by combined anti-CD4 mAb, TGF-β, and RA treatment.
    Schliesser U; Chopra M; Beilhack A; Appelt C; Vogel S; Schumann J; Panov I; Vogt K; Schlickeiser S; Olek S; Wood K; Brandt C; Volk HD; Sawitzki B
    Eur J Immunol; 2013 Dec; 43(12):3291-305. PubMed ID: 23946112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.